免疫系统
小RNA
免疫学
先天免疫系统
炎症
非编码RNA
类风湿性关节炎
疾病
获得性免疫系统
医学
生物
基因
遗传学
病理
作者
Roghayeh Tofigh,Mohammadali Hosseinpourfeizi,Behzad Baradaran,Shahram Teimourian,Reza Safaralizadeh
出处
期刊:Life Sciences
[Elsevier]
日期:2023-01-01
卷期号:315: 121367-121367
标识
DOI:10.1016/j.lfs.2023.121367
摘要
Rheumatoid arthritis (RA) is a systemic and chronic inflammatory disease categorized by continuous synovitis in the joints and systemic inflammatory responses that can cause lifelong disability. The major cause of RA is the dysregulation of the immune response. The development of RA disease includes multiplex association of several interleukins and cells, which leads to synovial cell growth, cartilage and bone damage. The primary stage of RA disease is related to the modification of both the innate and adaptive immune systems, which leads to the formation of autoantibodies. This process results in many damaged molecules and epitope spreading. Both the innate (e.g., dendritic cells, macrophages, and neutrophils) and acquired immune cells (e.g., T and B lymphocytes) will increase and continue the chronic inflammatory condition in the next stages of the RA disease. In recent years, non-coding RNAs have been proved as significant controllers of biological functions, especially immune cell expansion and reactions. Non-coding RNAs were primarily containing microRNA (miRNA), long non-coding RNA (lncRNA), and circular RNA (circRNA). Various studies confirmed non-coding RNAs as hopeful markers for diagnosing and curing RA. This review will describe and cover existing knowledge about RA pathogenesis, which might be favorable for discovering possible ncRNA markers for RA.
科研通智能强力驱动
Strongly Powered by AbleSci AI